EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 270 filers reported holding EXELIXIS INC in Q3 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $213,510 | +21.0% | 11,000 | 0.0% | 0.11% | +32.5% |
Q4 2022 | $176,440 | +2.6% | 11,000 | 0.0% | 0.08% | -12.1% |
Q3 2022 | $172,000 | -24.9% | 11,000 | 0.0% | 0.09% | -9.9% |
Q2 2022 | $229,000 | -8.0% | 11,000 | 0.0% | 0.10% | +27.8% |
Q1 2022 | $249,000 | +23.9% | 11,000 | 0.0% | 0.08% | -11.2% |
Q4 2021 | $201,000 | -12.6% | 11,000 | +0.9% | 0.09% | -19.1% |
Q3 2021 | $230,000 | +15.6% | 10,900 | 0.0% | 0.11% | +19.6% |
Q2 2021 | $199,000 | -19.1% | 10,900 | 0.0% | 0.09% | -25.8% |
Q1 2021 | $246,000 | +12.3% | 10,900 | 0.0% | 0.12% | +6.0% |
Q4 2020 | $219,000 | -18.0% | 10,900 | 0.0% | 0.12% | -34.3% |
Q3 2020 | $267,000 | +3.1% | 10,900 | 0.0% | 0.18% | +12.7% |
Q2 2020 | $259,000 | +37.8% | 10,900 | 0.0% | 0.16% | +17.0% |
Q1 2020 | $188,000 | -2.1% | 10,900 | 0.0% | 0.14% | +68.8% |
Q4 2019 | $192,000 | -78.4% | 10,900 | -69.7% | 0.08% | -79.1% |
Q2 2017 | $887,000 | +14.3% | 36,000 | +0.6% | 0.38% | +2.4% |
Q1 2017 | $776,000 | +80.0% | 35,800 | +23.9% | 0.37% | +65.0% |
Q4 2016 | $431,000 | – | 28,900 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,966,038 | $282,918,000 | 60.81% |
NEXTHERA CAPITAL LP | 1,735,030 | $30,745,000 | 5.89% |
GREAT POINT PARTNERS LLC | 2,075,000 | $36,769,000 | 5.73% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 704,534 | $9,574,000 | 4.55% |
Matrix Capital Management Company, LP | 10,000,000 | $177,200,000 | 4.38% |
Consonance Capital Management LP | 3,879,050 | $68,737,000 | 3.70% |
Rhenman & Partners Asset Management AB | 1,261,414 | $22,352,000 | 2.24% |
BB BIOTECH AG | 2,785,000 | $49,350,000 | 1.31% |
CAPITAL MANAGEMENT CORP /VA | 285,575 | $5,060,000 | 1.29% |
TEALWOOD ASSET MANAGEMENT INC | 155,376 | $2,753,000 | 1.03% |